Beranda › Skleroderma › Maryland › Baltimore
Uji klinis Skleroderma di Baltimore, MD
6 studi untuk Skleroderma mencari peserta di lokasi sekitar Baltimore (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Menerima pesertaFase 3
- Johns Hopkins Hospital, Baltimore
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Menerima pesertaFase 2
- Johns Hopkins Asthma and Allergy Center, Baltimore
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Menerima pesertaFase 1
- Johns Hopkins Hospital, Baltimore
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Menerima pesertaFase 2/3
- GSK Investigational Site, Baltimore
Platform Clinical Study for Conquering Scleroderma
Menerima pesertaFase 2
- Johns Hopkins University School of Medicine, Baltimore
Uji klinis Skleroderma di kota lain
- New York City, NY11 studi
- Ann Arbor, MI10 studi
- Chicago, IL10 studi
- Houston, TX9 studi
- Boston, MA7 studi
- Durham, NC7 studi
- Los Angeles, CA7 studi
- New Orleans, LA6 studi
- Philadelphia, PA6 studi
- Dallas, TX5 studi
- Pittsburgh, PA5 studi
- Plantation, FL4 studi
Studi lain di Baltimore
- Kanker Paru Non-Sel Kecil60 studi
- Kanker Payudara47 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Kanker (semua jenis)37 studi
- Kanker Kolorektal31 studi
- Kanker Pankreas31 studi
- Kanker Metastatik28 studi
- Obesitas25 studi
- Gagal Jantung24 studi
- Kanker Kandung Kemih24 studi
- Stroke22 studi
Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.